GoodRx Now Offers 40% More Savings on Nearly 200 Medications at Walgreens
11 9월 2023 - 10:00PM
Business Wire
Lower prices offer added savings on top
medications for heart disease, men’s health, mental health and
more
GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings
and information, today announced a new initiative at Walgreens to
reduce prices on nearly 200 prescription medications by an average
of 40%, with even greater savings available for select medications.
Consumers can now purchase many popular prescriptions at Walgreens
for less than $15 for a 30-day fill, without any deductibles,
restrictions, paperwork, approvals or quantity limitations.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230911100555/en/
GoodRx offers more savings on common
prescriptions at Walgreens. (Graphic: Business Wire)
The new lower prices include medications for many health
concerns, including heart disease and mental health, as well as
categories often not covered by insurance, such as acne, insomnia,
men’s health, and weight loss.
“Americans shouldn’t have to jump through hoops to be able to
afford their medications,” said Jim Sheninger, Pharmacy Strategy
Officer of GoodRx. “Walgreens has been part of our network since
nearly the beginning, enabling us to offer their customers lower
prices on the most commonly prescribed medications to make it even
easier for people to save money. We believe everyone deserves
affordable healthcare, and this initiative will help more Americans
access the treatment they need.”
The following is a sample list of the most common
prescriptions available now for lower prices at Walgreens with a
GoodRx coupon:
Medication
Previous Price
Lower Price
% Savings
Heart Disease
Amlodipine
$21.83
$6.69
69%
Lisinopril
$12.91
$7.27
44%
Ezetimibe
$34.99
$20.51
41%
Atorvastatin
$21.99
$13.75
37%
Men’s Health
Finasteride
$71.58
$16.88
76%
Vardenafil
$149.62
$38.53
74%
Tadalafil (Cialis)
$29.99
$16.90
44%
Sildenafil
$25.99
$19.69
24%
Mental Health
Escitalopram
$34.15
$14.05
59%
Bupropion XL
$29.99
$15.62
48%
Fluoxetine
$25.50
$13.49
47%
Sertraline
$19.99
$13.84
31%
For years, GoodRx has provided Walgreens customers with
significant cost savings on their medications. Now, for a limited
time, medications are even more affordable for the millions of
customers Walgreens serves each day at its nearly 9,000 retail
locations.
With rising medication prices and high inflation making it
difficult for many Americans to manage their healthcare costs,
GoodRx aims to make it easier than ever for Walgreens customers to
save on prescriptions and adhere to treatment plans.
To search prescription savings at Walgreens and compare prices,
consumers can visit www.GoodRx.com/Walgreens.
About GoodRx
GoodRx is a leading resource for healthcare savings and
information that makes healthcare affordable and convenient for all
Americans. We offer consumers free access to transparent and lower
prices for brand and generic medications, affordable and convenient
medical provider consultations via telehealth, and comprehensive
healthcare research and information. Since 2011, we have helped
consumers save over $60 billion and are one of the most downloaded
medical apps over the past decade.
GoodRx periodically posts information that may be important to
investors on its investor relations website at
https://investors.goodrx.com. We intend to use our website as a
means of disclosing material nonpublic information and for
complying with our disclosure obligations under Regulation FD.
Accordingly, investors and potential investors are encouraged to
consult GoodRx’s website regularly for important information, in
addition to following GoodRx’s press releases, filings with the
Securities and Exchange Commission (the “SEC”) and public
conference calls and webcasts. The information contained on, or
that may be accessed through, GoodRx’s website is not incorporated
by reference into, and is not a part of, this press release.
GoodRx Forward-Looking
Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements contained in this press release that do not
relate to matters of historical fact should be considered
forward-looking statements, including, without limitation,
statements regarding consumer savings and the benefits of our
offerings to consumers and at any pharmacies. These statements are
neither promises nor guarantees, but involve known and unknown
risks, uncertainties and other important factors that may cause our
actual results, performance or achievements to be materially
different from any future results, performance or achievements
expressed or implied by the forward-looking statements, including,
but not limited to, risks relating to our ability to achieve broad
market education and change consumer purchasing habits, changes in
medication pricing and pricing structures, our reliance on a
limited number of industry participants, the competitive nature of
our industry, risks related to government regulation of the
internet, e-commerce, consumer data and privacy, information
technology and cyber-security and the important factors discussed
in the sections entitled “Risk Factors” in GoodRx’s Annual Report
on Form 10-K for the year ended December 31, 2022, as updated by
our Quarterly Report on Form 10-Q for the quarter ended June 30,
2023, and our other filings with the Securities and Exchange
Commission. These factors could cause actual results to differ
materially from those indicated by the forward-looking statements
made in this press release. Any such forward-looking statements
represent management’s estimates as of the date of this press
release. While we may elect to update such forward-looking
statements at some point in the future, we disclaim any obligation
to do so, even if subsequent events cause our views to change.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230911100555/en/
GoodRx Media Contact Lauren Casparis press@goodrx.com
GoodRx (NASDAQ:GDRX)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
GoodRx (NASDAQ:GDRX)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024